255 related articles for article (PubMed ID: 2293609)
1. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
Walters DE; Chapman CD; Howard SG
J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
[TBL] [Abstract][Full Text] [Related]
2. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
Kito S; Shimoyama M; Arakawa R
Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
See RE
Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
[TBL] [Abstract][Full Text] [Related]
4. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
Zetterström T; Sharp T; Ungerstedt U
Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
[TBL] [Abstract][Full Text] [Related]
5. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs.
Radhakishun FS; Korf J; Venema K; Westerink BH
Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209
[TBL] [Abstract][Full Text] [Related]
6. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Hashitani T; Mizukawa K; Kumazaki M; Nishino H
Neurosci Res; 1998 Jan; 30(1):43-52. PubMed ID: 9572579
[TBL] [Abstract][Full Text] [Related]
7. An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis.
Sharp T; Zetterström T; Ungerstedt U
J Neurochem; 1986 Jul; 47(1):113-22. PubMed ID: 3711893
[TBL] [Abstract][Full Text] [Related]
8. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
Walters DE; Howard SG
Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
[TBL] [Abstract][Full Text] [Related]
9. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
Salamone JD; Keller RW; Zigmond MJ; Stricker EM
Brain Res; 1989 May; 487(2):215-24. PubMed ID: 2786443
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
Commissiong JW; Slimovitch C; Toffano G
Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
[TBL] [Abstract][Full Text] [Related]
11. Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats.
Chapman CD; Gazzara RA; Howard SG
Neuropharmacology; 1990 Apr; 29(4):319-25. PubMed ID: 2342635
[TBL] [Abstract][Full Text] [Related]
12. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
[TBL] [Abstract][Full Text] [Related]
13. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
See RE; Murray CE
Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
[TBL] [Abstract][Full Text] [Related]
14. Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat.
Westerink BH; Damsma G; De Vries JB; Koning H
Eur J Pharmacol; 1987 Mar; 135(2):123-8. PubMed ID: 3582491
[TBL] [Abstract][Full Text] [Related]
15. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
Nomura Y; Komori T; Okuda S; Segawa T
Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
Melamed E; Durst R; Frucht Y; Globus M
Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
[TBL] [Abstract][Full Text] [Related]
17. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
18. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.
Imperato A; Di Chiara G
J Neurosci; 1984 Apr; 4(4):966-77. PubMed ID: 6716134
[TBL] [Abstract][Full Text] [Related]
19. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats.
Guinetdinov RR; Bogdanov MB; Pogorelov VM; Kudrin VS; Rayevsky KS
Neuropharmacology; 1991 Nov; 30(11):1251-4. PubMed ID: 1685561
[TBL] [Abstract][Full Text] [Related]
20. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
Moleman P; Bruinvels J; van Valkenburg CF
Life Sci; 1978 Aug; 23(6):611-5. PubMed ID: 692284
[No Abstract] [Full Text] [Related]
[Next] [New Search]
